Glycomimetics
Waltham, US · 71 employees on LinkedIn · 2 known investors
Find your way into Glycomimetics
Sign up to see every warm intro you have to Glycomimetics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Glycomimetics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GlycoMimetics is a company developing cancer therapies, aiming to advance treatment options for people living with cancer. It operates in the oncology-focused biotech field.
Investors · 2
New Enterprise Associates (NEA)listed by New Enterprise Associates (NEA)Menlo Park · $200K – $40M
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
Sanofi Ventureslisted by Sanofi VenturesCambridge · $5M
How we know: Sanofi Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Glycomimetics do?
- GlycoMimetics is a company developing cancer therapies, aiming to advance treatment options for people living with cancer. It operates in the oncology-focused biotech field.
- Who are Glycomimetics's investors?
- Glycomimetics's investors include New Enterprise Associates (NEA), Sanofi Ventures.
- Where is Glycomimetics headquartered?
- Glycomimetics is headquartered in Waltham, US.

